Ligand Pharmaceuticals
LGND
#4130
Rank
NZ$3.92 B
Marketcap
$207.59
Share price
4.89%
Change (1 day)
73.06%
Change (1 year)

EPS for Ligand Pharmaceuticals (LGND)

EPS in 2023 (TTM): $2.53

According to Ligand Pharmaceuticals's latest financial reports the company's current EPS (TTM) is $2.78. In 2022 the company made an earnings per share (EPS) of -$3.50 a decrease over its 2021 EPS that were of $6.12.

EPS history for Ligand Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.53-172.37%
2022-$3.50-157.23%
2021$6.12-2571.43%
2020-$0.25-100.46%
2019$54.14353.48%
2018$11.941025%
2017$1.06-700%
2016-$0.18-100.87%
2015$20.451859.32%
2014$1.045.36%
2013$0.998.0704505322479E+18%
2012$0.0000000000-100%
2011$0.87-194.23%
2010-$0.92548.38%
2009-$0.14-98.7%
2008-$10.93-136.52%
2007$29.93-787.8%
2006-$4.35-14.58%
2005-$5.09-21.31%
2004-$6.47-55.15%
2003-$14.4381.33%
2002-$7.962.74%
2001-$7.75-45.93%
2000-$14.33-14.56%
1999-$16.77-45.52%
1998-$30.78-3.97%
1997-$32.05132.31%
1996-$13.80

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$25.03 801.27%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.64-122.93%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.19 122.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
$3.22 16.03%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.29 18.47%๐Ÿ‡บ๐Ÿ‡ธ USA
$9.60 245.81%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.02 152.87%๐Ÿ‡บ๐Ÿ‡ธ USA
$9.06 226.11%๐Ÿ‡บ๐Ÿ‡ธ USA
$24.91 797.15%๐Ÿ‡บ๐Ÿ‡ธ USA